| 前收市價 | 1.1000 |
| 開市 | 1.1000 |
| 買盤 | 0.0000 |
| 賣出價 | 4.8000 |
| 拍板 | 37.50 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 1.1000 - 1.1000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 4 |
ZacksWhy Is Catalent (CTLT) Up 0.4% Since Last Earnings Report?
Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksCatalent's (CTLT) Latest Partnership to Boost Clinical Trials
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
ZacksCatalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
